QuidelOrtho
QDEL
#3648
Rank
โ‚น242.77 B
Marketcap
โ‚น3,610
Share price
-1.32%
Change (1 day)
-38.40%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.

Revenue for QuidelOrtho (QDEL)

Revenue in 2024 (TTM): โ‚น235.07 Billion

According to QuidelOrtho's latest financial reports the company's current revenue (TTM ) is โ‚น239.53 Billion. In 2023 the company made a revenue of โ‚น249.56 Billion a decrease over the revenue in the year 2022 that were of โ‚น270.26 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for QuidelOrtho from 1996 to 2024

20002005201020152020โ‚น50Bโ‚น100Bโ‚น150Bโ‚น200Bโ‚น250Bโ‚น300Bcompaniesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น235.07 B-5.8%
2023 โ‚น249.56 B-7.66%
2022 โ‚น270.26 B113.77%
2021 โ‚น126.42 B4.04%
2020 โ‚น121.52 B218.6%
2019 โ‚น38.14 B4.45%
2018 โ‚น36.51 B105.93%
2017 โ‚น17.73 B36.2%
2016 โ‚น13.02 B-0.1%
2015 โ‚น13.03 B12.41%
2014 โ‚น11.59 B7%
2013 โ‚น10.83 B27.08%
2012 โ‚น8.52 B1.64%
2011 โ‚น8.39 B65.2%
2010 โ‚น5.07 B-33.37%
2009 โ‚น7.62 B23.77%
2008 โ‚น6.15 B32.92%
2007 โ‚น4.63 B-1.32%
2006 โ‚น4.69 B13.05%
2005 โ‚น4.15 B23.44%
2004 โ‚น3.36 B-22.29%
2003 โ‚น4.33 B18.39%
2002 โ‚น3.65 B3.57%
2001 โ‚น3.53 B11.99%
2000 โ‚น3.15 B
1998 โ‚น2.10 B17.99%
1997 โ‚น1.78 B27.63%
1996 โ‚น1.39 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น28.31 B-88.18%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.715 T 616.12%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.601 T 1,403.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น19.06 B-92.04%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.702 T 610.86%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น285.42 B 19.16%๐Ÿ‡บ๐Ÿ‡ธ USA